The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
SE |
|
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC
PAR:CCN
|
FR |
|
S
|
Safran SA
XMUN:SEJ1
|
FR |
|
R
|
Rolls-Royce Holdings PLC
DUS:RRU
|
UK |
|
Canagold Resources Ltd
F:CANA
|
CA |
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
Assicurazioni Generali SpA
MIL:G
|
IT |
|
C
|
CNFinance Holdings Ltd
NYSE:CNF
|
CN |
|
Wolters Kluwer NV
F:WOS
|
NL |
|
A
|
Axon Enterprise Inc
DUS:TCS
|
US |
|
Nippon Building Fund Inc
TSE:8951
|
JP |
|
I
|
Investment Friends SE
WSE:IFR
|
EE |
|
JD Sports Fashion PLC
F:9JD
|
UK |
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
R
|
Republic Services Inc
F:RPU
|
US |
|
T
|
Transition Metals Corp
OTC:TNTMF
|
CA |
|
Arverne Group SA
PAR:ARVEN
|
FR |
|
W
|
Western Digital Corp
DUS:WDC
|
US |
|
111 Inc
NASDAQ:YI
|
CN |
|
Logic Instrument SA
PAR:ALLOG
|
FR |
|
KP ENERGY Ltd
BSE:539686
|
IN |
|
A
|
Adaro Energy Indonesia TBK PT
F:A64
|
ID |
Swedish Orphan Biovitrum AB (publ) (SOBI)’s 12-month stock price forecast through October 2027 has a consensus target of kr525.3, implying 23% upside. The forecast is based on price targets from 16 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
SOBI is 525.3 SEK with a low forecast of 353.5 SEK and a high forecast of 619.5 SEK.
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.
The compound annual growth rate for Operating Income over the next 8 years is 9%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 603%.
The compound annual growth rate for Net Income over the next 8 years is 43%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more